Anti-angiogenic active immunotherapy: a new approach to cancer treatment

作者:Pan Jianping*; Jin Pengfeng; Yan Jie; Kabelitz Dieter
来源:Cancer Immunology, Immunotherapy, 2008, 57(8): 1105-1114.
DOI:10.1007/s00262-008-0452-2

摘要

Tumor angiogenesis plays an important role in tumor growth, aggression and metastasis. Many molecules have been demonstrated as positive regulators of angiogenesis, including vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), epidermal growth factor (EGF), and others. In recent years, significant progress has been made in the research on anti-angiogenic strategies for tumor therapies. In this review, anti-angiogenic active immunotherapies for tumors based on vaccination with xenogeneic homologous molecules and non-xenogeneic homologous molecules are discussed.